ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

MBD4 frameshift mutation caused by DNA mismatch repair deficiency enhances cytotoxicity by trifluridine, an active antitumor agent of TAS-102, in colorectal cancer cells.

Suzuki Satoshi; Iwaizumi Moriya; Yamada Hidetaka; Sugiyama Tomohiro; Hamaya Yasushi; Furuta Takahisa; Kanaoka Shigeru; Sugimura Haruhiko; Miyajima Hiroaki; Osawa Satoshi; Carethers John M; Sugimoto Kenuniversity of michigan
ONCOTARGET2018-2-20DOI: 10.18632/oncotarget.22484
6阅读
引用收藏
分享

摘要

Backgrounds: Trifluridine is an active antitumor component of TAS-102 that resembles 5-fluorouracil. Although patients with advanced colorectal cancer (CRC) exhibiting a mismatch repair (MMR) deficiency reportedly do not benefit from 5-fluorouracil-based chemotherapy and we previously reported that truncated methyl-CpG binding domain protein 4 (MBD4) enhances 5-fluorouracil cytotoxicity in MMR-deficient CRC cells, little is known regarding the effect of MMR deficiency on trifluridine cytotoxicity in CRC. Aim: We investigated whether trifluridine induces cytotoxicity in a DNA MMR-dependent manner and evaluated how truncated MBD4 alters trifluridine cytotoxicity. Methods: We utilized the human CRC cell lines HCT116 (hMLH1-deficient cells) and HCT116+ch3 (hMLH1-restored cells) and compared their sensitivities to trifluridine. And we established 5-fluorouracil-refractory hMLH1-deficient cells and analyzed trifluridine cytotoxicity. Finally, we established truncated MBD4 overexpressed CRC cell lines, and compared trifluridine sensitivity.Results: The sensitivities of HCT116 and HCT116+ch3 to trifluridine were comparable. 5-Fluorouracil-refractory hMLH1-deficient cells treated with trifluridine showed an equal or greater sensitivity than non-5-fluorouracil-refractory cells. Moreover, MBD4tru cells were more sensitive than the control cells to trifluridine.Conclusions: Trifluridine induces cytotoxicity independently of the DNA MMR status as well as under 5-fluorouracil-refractory conditions, and the MBD4 frameshift mutation enhances trifluridine cytotoxicity.

学科与关键词

关键词
MBD4colorectal cancerframeshift mutationmicrosatellite instabilitytrifluridine
相关
加载中…
  • Truncation of MBD4 predisposes to reciprocal chromosomal translocations and alters the response to therapeutic agents in colon cancer cells
    Abdel Rahman W M*; Knuutila S; Peltomäki P; Harrison D J; Bader S ADNA Repair, 2008, 7(2): 321-328.被引 13
  • Inhibition of Human Uracil DNA Glycosylase Sensitizes a Large Fraction of Colorectal Cancer Cells to 5-Fluorodeoxyuridine and Raltitrexed but Not Fluorouracil
    Christenson, Eric S.; Gizzi, Anthony; Cui, Junru; Egleston, Matthew; Seamon, Kyle J.; DePasquale, Michael; Orris, Benjamin; Park, Ben H.; Stivers, James T.*Molecular Pharmacology, 2021, 99(6): 412-425.
  • Effects of Rad9 mutants with impaired DNA mismatch repair function on tumorigenesis of colorectal ;cancer
    Kong Man; An Lili; Hu Zhishang; Li Kaimin; Zhao Yun; Cai Zeyuan; Sun Jiya; Wang Haifeng; Zhang Shucai; Zhang Zhenya2016.
查看全部 →

发表信息

论文状态
公开发表
期刊
ONCOTARGET
发表日期
2018-02-20
卷期
第 9 卷, 第 14 期
页码
11477-11488
DOI
10.18632/oncotarget.22484
语言
ENGLISH
成果收录
PUBMED

作者

  • S

    Suzuki Satoshi (第一作者)

  • I

    Iwaizumi Moriya

查看全部 12 位作者收起作者
  • Y

    Yamada Hidetaka

  • S

    Sugiyama Tomohiro

  • H

    Hamaya Yasushi

  • F

    Furuta Takahisa

  • K

    Kanaoka Shigeru

  • S

    Sugimura Haruhiko

  • M

    Miyajima Hiroaki

  • O

    Osawa Satoshi

  • C

    Carethers John M

  • S

    Sugimoto Ken

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417